Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
SLC-3010 is a conjugate of IL-2 linked to an anti-IL2 antibody, which potentially induces increased antitumor immune response and inhibits tumor growth (Cancer Res (2021) 81 (13_Supplement): 689).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Gemcitabine + SLC-3010||Gemcitabine SLC-3010||0||1|